Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Clarkson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Natural Science Illustration|July 12, 2022
Codifying Composable Graphic LibrariesMelissa Clarkson
Current Genetics|August 20, 2002
A chimeric open reading frame associated with cytoplasmic male sterility in alloplasmic wheat with Triticum timopheevi mitochondria is present in several Triticum and Aegilops species, barley, and ryeCharles Hedgcoth, Ahmed M el-Shehawi, Ping Wei, et al.
Cureus|December 29, 2021
Time to Treatment With Nivolumab or Pembrolizumab for Patients With Advanced Melanoma in Everyday PracticeDoran Ksienski, Pauline T Truong, Nicole S Croteau, et al.
Journal of Geriatric Oncology|May 6, 2024
Advanced cutaneous squamous cell carcinoma: Impact of age on the safety and efficacy of cemiplimab and the prognostic significance of blood biomarkersDoran Ksienski, Pauline T Truong, Jeffrey N Bone, et al.
Targeted Oncology|November 3, 2024
Durvalumab Following Chemoradiotherapy for Stage III Non-small Cell Lung Cancer: Differences in Survival Based on Age and Post-Progression Systemic TherapyDoran Ksienski, Pauline T Truong, Jeffrey N Bone, et al.
Plos One|May 9, 2018
Repeated mild traumatic brain injury can cause acute neurologic impairment without overt structural damage in juvenile ratsAlicia Meconi, Ryan C Wortman, David K Wright, et al.
Journal of Geriatric Oncology|October 16, 2021
Immune related adverse events and treatment discontinuation in patients older and younger than 75 years with advanced melanoma receiving nivolumab or pembrolizumabDoran Ksienski, Pauline T Truong, Nicole S Croteau, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Towards understanding craniofacial abnormalities: the ontology of craniofacial development and malformationJames F Brinkley, Jose Lv Mejino, Landon T Detwiler, et al.
Translational Lung Cancer Research|August 14, 2023
First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemicSuganija Lakkunarajah, Pauline T Truong, Jeffrey N Bone, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2022
Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemicDoran Ksienski, Sapna Gupta, Pauline T Truong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Natural Science Illustration|July 12, 2022
Codifying Composable Graphic LibrariesMelissa Clarkson
Current Genetics|August 20, 2002
A chimeric open reading frame associated with cytoplasmic male sterility in alloplasmic wheat with Triticum timopheevi mitochondria is present in several Triticum and Aegilops species, barley, and ryeCharles Hedgcoth, Ahmed M el-Shehawi, Ping Wei, et al.
Cureus|December 29, 2021
Time to Treatment With Nivolumab or Pembrolizumab for Patients With Advanced Melanoma in Everyday PracticeDoran Ksienski, Pauline T Truong, Nicole S Croteau, et al.
Journal of Geriatric Oncology|May 6, 2024
Advanced cutaneous squamous cell carcinoma: Impact of age on the safety and efficacy of cemiplimab and the prognostic significance of blood biomarkersDoran Ksienski, Pauline T Truong, Jeffrey N Bone, et al.
Targeted Oncology|November 3, 2024
Durvalumab Following Chemoradiotherapy for Stage III Non-small Cell Lung Cancer: Differences in Survival Based on Age and Post-Progression Systemic TherapyDoran Ksienski, Pauline T Truong, Jeffrey N Bone, et al.
Plos One|May 9, 2018
Repeated mild traumatic brain injury can cause acute neurologic impairment without overt structural damage in juvenile ratsAlicia Meconi, Ryan C Wortman, David K Wright, et al.
Journal of Geriatric Oncology|October 16, 2021
Immune related adverse events and treatment discontinuation in patients older and younger than 75 years with advanced melanoma receiving nivolumab or pembrolizumabDoran Ksienski, Pauline T Truong, Nicole S Croteau, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Towards understanding craniofacial abnormalities: the ontology of craniofacial development and malformationJames F Brinkley, Jose Lv Mejino, Landon T Detwiler, et al.
Translational Lung Cancer Research|August 14, 2023
First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemicSuganija Lakkunarajah, Pauline T Truong, Jeffrey N Bone, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2022
Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemicDoran Ksienski, Sapna Gupta, Pauline T Truong, et al.
Pageof 2